Inventor
ELLEN FILVAROFF
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
C07KPeptides6%
PatentTitleYear
12,474,342Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies202512,396,995Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use202512,357,633Methods of treating cancer by targeting cold tumors202511,583,536Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use202311,460,471Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to CELGENE CORP (5)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 5 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |